First Time Loading...

RemeGen Co Ltd
HKEX:9995

Watchlist Manager
RemeGen Co Ltd Logo
RemeGen Co Ltd
HKEX:9995
Watchlist
Price: 31.4 HKD -2.79%
Updated: May 13, 2024

RemeGen Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RemeGen Co Ltd
Research & Development Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
RemeGen Co Ltd
HKEX:9995
Research & Development
-¥1.2B
CAGR 3-Years
-37%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Research & Development
-¥12.5B
CAGR 3-Years
-13%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Research & Development
-¥2.2B
CAGR 3-Years
-6%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Research & Development
-¥1.1B
CAGR 3-Years
-54%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Research & Development
-¥988.6m
CAGR 3-Years
-47%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Research & Development
-¥168.2m
CAGR 3-Years
-54%
CAGR 5-Years
-44%
CAGR 10-Years
N/A

See Also

What is RemeGen Co Ltd's Research & Development?
Research & Development
-1.2B CNY

Based on the financial report for Dec 31, 2023, RemeGen Co Ltd's Research & Development amounts to -1.2B CNY.

What is RemeGen Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-41%

Over the last year, the Research & Development growth was -35%. The average annual Research & Development growth rates for RemeGen Co Ltd have been -37% over the past three years , -41% over the past five years .